MedPath

Prospective Evaluation of the Proceed Ventral Patch With and Without Laparoscopic Evaluation

Not Applicable
Completed
Conditions
Ventral Hernias
Umbilical Hernias
Interventions
Device: Proceed Ventral Patch placement
Registration Number
NCT01183325
Lead Sponsor
University Hospital, Ghent
Brief Summary

For small (2-3cm) ventral and umbilical hernias the discussion for primary suture repair or the use of mesh continues.

About 5 years ago the Ventralex patch was introduced, which combines a layer of PTFE mesh with a small polypropylene mesh and includes a circular memory ring. Despite the elegance of using this patch, recent experience showed several drawbacks both in design and efficacy (3).

With the recent development of the Proceed Ventral Patch (PVP), new elements have been introduced to overcome some of these issues.

The aim of this study is to evaluate the efficacy of clinical placement of the PVP in the intra-abdominal position in the treatment of small ventral hernias.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Adult patient
  • Written informed consent
  • Umbilical, primary ventral hernias smaller than 3cm diameter
Exclusion Criteria
  • Hernias larger than 3cm
  • Recurrence
  • Children
  • Emergency cases
  • Incisional hernias

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Proceed Ventral Patch placementProceed Ventral Patch placementPlacement of a Proceed Ventral Patch for umbilical and small ventral hernias less than 3cm diameter with and without laparoscopic control
Primary Outcome Measures
NameTimeMethod
Percentage of adequately placed patchesAt T 0 days
Secondary Outcome Measures
NameTimeMethod
Reasons for inadequate positioningAt T 0 days
Perioperative morbidity rateWithin 30 days
Number of patients needed a repositioning of the patchAt T 0 days
Number of repositioning necessaryAt T 0 days
Complication ratioAt 1 year
Pre- and postoperative painAt T 0 day, T 30 days and T 1 year
Recurrence rate at 1 yearAt 1 year

Trial Locations

Locations (2)

Imelda Hospital

🇧🇪

Bonheiden, Belgium

University Hospital Ghent

🇧🇪

Ghent, Belgium

© Copyright 2025. All Rights Reserved by MedPath